You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • SAT0164 Immune Reconstitution 20 Years after Treatment with Alemtuzumab in A Rheumatoid Arthritis Cohort: Implications for Lymphocyte Depleting Therapies

Article info

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - other biologic treatment
SAT0164 Immune Reconstitution 20 Years after Treatment with Alemtuzumab in A Rheumatoid Arthritis Cohort: Implications for Lymphocyte Depleting Therapies

Authors

  • F.A.H. Cooles 1National Institute for Health Research Newcastle Biomedical Research Centre at Newcastle upon Tyne Hospitals Foundation Trust and Newcastle University, Newcastle upon Tyne PubMed articlesGoogle scholar articles
  • A.E. Anderson 1National Institute for Health Research Newcastle Biomedical Research Centre at Newcastle upon Tyne Hospitals Foundation Trust and Newcastle University, Newcastle upon Tyne PubMed articlesGoogle scholar articles
  • T. Drayton 2Addenbrooke's NHS Trust, Cambridge, United Kingdom PubMed articlesGoogle scholar articles
  • R.A. Harry 1National Institute for Health Research Newcastle Biomedical Research Centre at Newcastle upon Tyne Hospitals Foundation Trust and Newcastle University, Newcastle upon Tyne PubMed articlesGoogle scholar articles
  • J. Diboll 1National Institute for Health Research Newcastle Biomedical Research Centre at Newcastle upon Tyne Hospitals Foundation Trust and Newcastle University, Newcastle upon Tyne PubMed articlesGoogle scholar articles
  • L. Munro 1National Institute for Health Research Newcastle Biomedical Research Centre at Newcastle upon Tyne Hospitals Foundation Trust and Newcastle University, Newcastle upon Tyne PubMed articlesGoogle scholar articles
  • N. Thalayasingam 1National Institute for Health Research Newcastle Biomedical Research Centre at Newcastle upon Tyne Hospitals Foundation Trust and Newcastle University, Newcastle upon Tyne PubMed articlesGoogle scholar articles
  • A.J.K. Östör 2Addenbrooke's NHS Trust, Cambridge, United Kingdom PubMed articlesGoogle scholar articles
  • J.D. Isaacs 1National Institute for Health Research Newcastle Biomedical Research Centre at Newcastle upon Tyne Hospitals Foundation Trust and Newcastle University, Newcastle upon Tyne PubMed articlesGoogle scholar articles

Citation

Cooles F, Anderson A, Drayton T, et al
SAT0164 Immune Reconstitution 20 Years after Treatment with Alemtuzumab in A Rheumatoid Arthritis Cohort: Implications for Lymphocyte Depleting Therapies
Annals of the Rheumatic Diseases 2016;75:725-726.

Publication history

  • First published July 15, 2016.
Online issue publication 
July 15, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions